4 research outputs found

    Proyecto Ideo Silver

    Get PDF
    Nuestro proyecto ofrece microfranquicias de joyas de lujo (plata 960), cuyos diseños están orientados a las mujeres modernas de los niveles socioeconómicos B, C y D, entre 21 y 35 años de edad que radican en Lima Metropolitana. Asimismo, hemos definido como segmento de clientes franquiciados a los microempresarios con experiencia en productos y/o servicios relacionados con la moda. Nuestro concepto de negocio hacia el franquiciado se resume en “Sea joyero en un día, de manera formal y sostenible”, sobre la base de nuestro know-how, marca, mínima inversión, garantía de por vida de nuestros productos, innovación abierta y soporte integral mediante la tecnología web. Las joyas de plata que ofrecemos logran cubrir las expectativas que más valora nuestro segmento de cliente final, es decir: diseño, precio, seguridad, lujo y calidad, mediante las siguientes características de nuestros productos: Joyas de plata 960, garantía de por vida y hereditaria, precios bajos, acabado tipo “oro blanco”, diseños sobrios y estilos modernos. Adicionalmente, de manera innovadora estamos incluyendo la facilidad de que el cliente final pueda “renovar las joyas de marca Ideo Silver”. Nuestro modelo de negocio presenta importantes barreras de entrada, basados en el poco acceso a proveedores (materia prima, plata, especialmente para joyas de lujo), alta diferenciación (certificado internacional de autenticidad, renovación de joyas, know-how) y falta de experiencia en la industria (producción de joyas 960, que es el más alto nivel de pureza permitida para la plata). En resumen, nuestra misión es: “Promover el autoempleo a través de microfranquicias de joyas de plata peruana de alta pureza (960), a bajo precio y con diseños preferidos por la mujer moderna, generar desarrollo económico para los socios y contribuir con el desarrollo sostenido del país”

    Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    Get PDF
    Background: In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive and collectively exhaustive list of diseases and injuries. Methods: GBD estimates incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) due to 369 diseases and injuries, for two sexes, and for 204 countries and territories. Input data were extracted from censuses, household surveys, civil registration and vital statistics, disease registries, health service use, air pollution monitors, satellite imaging, disease notifications, and other sources. Cause-specific death rates and cause fractions were calculated using the Cause of Death Ensemble model and spatiotemporal Gaussian process regression. Cause-specific deaths were adjusted to match the total all-cause deaths calculated as part of the GBD population, fertility, and mortality estimates. Deaths were multiplied by standard life expectancy at each age to calculate YLLs. A Bayesian meta-regression modelling tool, DisMod-MR 2.1, was used to ensure consistency between incidence, prevalence, remission, excess mortality, and cause-specific mortality for most causes. Prevalence estimates were multiplied by disability weights for mutually exclusive sequelae of diseases and injuries to calculate YLDs. We considered results in the context of the Socio-demographic Index (SDI), a composite indicator of income per capita, years of schooling, and fertility rate in females younger than 25 years. Uncertainty intervals (UIs) were generated for every metric using the 25th and 975th ordered 1000 draw values of the posterior distribution. Findings: Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates. After taking into account population growth and ageing, the absolute number of DALYs has remained stable. Since 2010, the pace of decline in global age-standardised DALY rates has accelerated in age groups younger than 50 years compared with the 1990–2010 time period, with the greatest annualised rate of decline occurring in the 0–9-year age group. Six infectious diseases were among the top ten causes of DALYs in children younger than 10 years in 2019: lower respiratory infections (ranked second), diarrhoeal diseases (third), malaria (fifth), meningitis (sixth), whooping cough (ninth), and sexually transmitted infections (which, in this age group, is fully accounted for by congenital syphilis; ranked tenth). In adolescents aged 10–24 years, three injury causes were among the top causes of DALYs: road injuries (ranked first), self-harm (third), and interpersonal violence (fifth). Five of the causes that were in the top ten for ages 10–24 years were also in the top ten in the 25–49-year age group: road injuries (ranked first), HIV/AIDS (second), low back pain (fourth), headache disorders (fifth), and depressive disorders (sixth). In 2019, ischaemic heart disease and stroke were the top-ranked causes of DALYs in both the 50–74-year and 75-years-and-older age groups. Since 1990, there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries. In 2019, there were 11 countries where non-communicable disease and injury YLDs constituted more than half of all disease burden. Decreases in age-standardised DALY rates have accelerated over the past decade in countries at the lower end of the SDI range, while improvements have started to stagnate or even reverse in countries with higher SDI. Interpretation: As disability becomes an increasingly large component of disease burden and a larger component of health expenditure, greater research and developm nt investment is needed to identify new, more effective intervention strategies. With a rapidly ageing global population, the demands on health services to deal with disabling outcomes, which increase with age, will require policy makers to anticipate these changes. The mix of universal and more geographically specific influences on health reinforces the need for regular reporting on population health in detail and by underlying cause to help decision makers to identify success stories of disease control to emulate, as well as opportunities to improve. Funding: Bill & Melinda Gates Foundation. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licens

    Five insights from the Global Burden of Disease Study 2019

    No full text
    corecore